Novel Stability Indicating RP-HPLC Method for The Estimation of Pinaverium Bromide in Tablet Formulation: Assay Development and Validation
 
More details
Hide details
1
Department of Pharmaceutical Chemistry, Kamla Nehru College of Pharmacy, Nagpur – 441108, Maharashtra, INDIA
CORRESPONDING AUTHOR
Debarshi Kar Mahapatra   

Department of Pharmaceutical Chemistry, Kamla Nehru College of Pharmacy, Nagpur−441108, Maharashta, India
Online publication date: 2016-12-07
Publication date: 2016-12-07
 
Eurasian J Anal Chem 2017;12(2):3–16
 
KEYWORDS
TOPICS
ABSTRACT
A selective RP-HPLC method has been developed for the estimation of pinaverium bromide (PB) in tablet dosage form. A Phenomenox C18 (250 x 4.6 mm i.d., particle size 5 µm) column with ammonium acetate buffer (pH 3.0) and acetonitrile (20:80) was employed as the mobile phase. The flow rate of 1 mL/min was utilized employing 214 nm as detector range where the drug eluted at 5.067 min. The method was validated further for linearity, accuracy, precision, and robustness according to the ICH guidelines. Forced degradation studies were performed under neutral, acidic, alkaline conditions along with thermal, photolysis and oxidative stress conditions, where the drug exhibited degradation and various peaks were monitored. The method was found to be linear over the range concentration range of 12.5-75.0 μg/mL (r2 values of 0.999), accurate (recovery of about 100.22% with % RSD of < 2%), highly precise (% RSD of < 2% in both intra-day and inter-day study), and robust enough to deliver accurate results when the chromatographic conditions were altered deliberately. No interference of additives/excipients was encountered while developing this method. Highest degradation was observed under oxidative stress condition. This method will help in the quantitative determination of PB and its degraded products.
 
REFERENCES (8)
1.
Beale, J. M. & Block, J. H. (2011). Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, Philadelphia: Lippincott Williams and Wilkins.
 
2.
Balaji, M., Chhabda, P. J., Srinivasarao, V., Appa Rao, K. M., & Ramakrishna K. (2014). Development and validation of a new and stability indicating LC method for analysis of pinaverium bromide in bulk drug and pharmaceutical dosage form. Pharma Science Monitor, 5(1), 164-175.
 
3.
Amruthraj, A. K., Venkatesha, B. M., & Ananda S. (2014). Rapid Ultra High Performance Liquid Chromatographic Assay of Pinaverium Bromide and its Stability studies. International Journal of Pharmaceutical Sciences Review and Research, 25(2), 62-66.
 
4.
Khalil, M. M., Issa, Y. M., Zayed, S. I., & Mohamed, N. A. (2015). Improved Determination of Pinaverium Bromide in Pharmaceutical Preparations and Human Urine Utilizing a Coated Wire Electrode. International Journal, 3(6), 638-652.
 
5.
Ren, J. M., Zhao, X., Wang, C. P., Sun, Q., Yin, L. X., & Zhang, Z. Q. (2011). A sensitive and specific liquid chromatography/tandem mass spectrometry method for determination of pinaverium bromide in human plasma: application to a pharmacokinetic study in healthy volunteers, Biomedical Chromatography, 25(12), 1369-1373.
 
6.
de Weerdt, G. A., Beke, R. P., Verdievel, H. G., Barbier, F., Jonckheere, J. A., & de Leenheer, A. P. (1983). Quantitative gas chromatographic mass spectrometric determination of pinaverium—bromide in human serum. Biological Mass Spectrometry, 10(3), 162-167.
 
7.
Patiño-Rodríguez, O., Zapata-Morales, J. R., Escobedo-Moratilla, A., de León-Cabrero, M. D., Torres-Roque, I., & Pérez-Urizar, J. (2015). Determination of Pinaverium Bromide in Human Plasma by a Sensitive and Robust UPLC–MS-MS Method and Application to a Pharmacokinetic Study in Mexican Subjects. Journal of Chromatographic Science, 53(8), 1373-1378.
 
8.
Deodhe, S. T., Dhabarde, D. M., Kamble, M. A., & Mahapatra, D. K. (2016). Development and validation of a novel stability indicating RP-HPLC method for the estimation of entecavir in tablet formulation. Eurasian Journal of Analytical Chemistry (in press).
 
eISSN:1306-3057